All Stories

  1. Estimating the clinical and economic burden of medically attended influenza in South Korea, stratified by age and comorbidity: A five-season hospital-based surveillance data, 2014/15–2018/19

    Article • PLOS One, September 2025, PLOS

    Professor Woo Joo Kim

  2. Collection and detection of SARS-CoV-2 in exhaled breath using face mask

    Article • PLOS One, August 2022, PLOS

    Professor Woo Joo Kim, Professor Sehyun Shin

  3. Invasive Endobronchial Mycobacterium kansasii Infection

    Article • American Review of Respiratory Disease, November 2019, American Thoracic Society

    Professor Woo Joo Kim

  4. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count

    Article • Human Vaccines & Immunotherapeutics, August 2019, Taylor & Francis

    Professor Woo Joo Kim

  5. Prospective Cohort Study on the Effectiveness of Influenza and Pneumococcal Vaccines in Preventing Pneumonia Development and Hospitalization

    Article • Clinical and Vaccine Immunology, December 2014, ASM Journals

    Professor Woo Joo Kim

  6. Age- and Influenza Activity-Stratified Case Definitions of Influenza-Like Illness: Experience from Hospital-Based Influenza Surveillance in South Korea

    Article • PLOS One, January 2014, PLOS

    Professor Woo Joo Kim

  7. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance

    Article • Journal of Infection and Chemotherapy, January 2014, Elsevier

    Professor Woo Joo Kim

  8. Immunogenicity and safety of Intanza®/IDflu®intradermal influenza vaccine in South Korean adults: A multicenter, randomized trial

    Article • Human Vaccines & Immunotherapeutics, September 2013, Taylor & Francis

    Professor Woo Joo Kim

  9. Hospital-based influenza morbidity and mortality surveillance system for influenza-like illnesses: a comparison with national influenza surveillance systems

    Article • Influenza and Other Respiratory Viruses, September 2013, Wiley

    Professor Woo Joo Kim

  10. Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine

    Article • Journal of Medical Virology, July 2013, Wiley

    Professor Woo Joo Kim

  11. Hospital-based influenza surveillance in Korea: Hospital-based influenza morbidity and mortality study group

    Article • Journal of Medical Virology, March 2013, Wiley

    Professor Woo Joo Kim

  12. Evaluation of five rapid diagnostic kits for influenza A/B virus

    Article • Journal of Virological Methods, January 2013, Elsevier

    Professor Woo Joo Kim

  13. Concurrent Tuberculosis and Influenza, South Korea

    Article • Emerging Infectious Diseases, January 2013, Centers for Disease Control and Prevention (CDC)

    Professor Woo Joo Kim

  14. Influenza Vaccines: Unmet Needs and Recent Developments

    Article • Infection and Chemotherapy, January 2013, Korean Society of Infectious Diseases and Korean Society for Chemotherapy (KAMJE)

    Professor Woo Joo Kim

  15. Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009–2011

    Article • The Journal of Microbiology, December 2012, Springer Science + Business Media

    Professor Woo Joo Kim

  16. The Clinical Usefulness of the SD Bioline Influenza Antigen Test® for Detecting the 2009 Influenza A (H1N1) Virus

    Article • Yonsei Medical Journal, January 2011, Yonsei University College of Medicine (KAMJE)

    Professor Woo Joo Kim

  17. Influenza Vaccination Coverage Rate and Factors Associated with Vaccination in People with Chronic Disease

    Article • January 2011, Korean Society of Infectious Diseases and Korean Society for Chemotherapy (KAMJE)

    Professor Woo Joo Kim, Dr. Byung Chul Chun

  18. The Evaluation of Policies on 2009 Influenza Pandemic in Korea

    Article • Journal of Preventive Medicine and Public Health, January 2010, Korean Society for Preventive Medicine (KAMJE)

    Professor Woo Joo Kim

  19. Epidemiological and Clinical Characteristics of Pandemic Influenza (H1N1 2009)

    Article • January 2009, Korean Society of Infectious Diseases and Korean Society for Chemotherapy (KAMJE)

    Professor Woo Joo Kim

  20. Vaccine Strategy for Influenza A (H1N1) Pandemic

    Article • Infection and Chemotherapy, January 2009, Korean Society of Infectious Diseases and Korean Society for Chemotherapy (KAMJE)

    Professor Woo Joo Kim

  21. Novel Influenza A/H1N1 Pandemic: Current Status and Prospects

    Article • Journal of Korean Medical Association, January 2009, Korean Medical Association (KAMJE)

    Professor Woo Joo Kim

  22. Diagnosis and Management of Novel Influenza A (H1N1)

    Article • Korean Journal of Family Medicine, January 2009, The Korean Academy of Family Medicine (KAMJE)

    Professor Woo Joo Kim

  23. Pandemic Influenza (H1N1 2009): Experience and Lessons

    Article • January 2009, Korean Society of Infectious Diseases and Korean Society for Chemotherapy (KAMJE)

    Professor Woo Joo Kim